Replies to post #27466 on Cerebain Biotech Corp (fka CBBT) (CBBT)

[fibonacci4]

Piecing together statements from several press releases, it's pretty clear to me the synergy between PKG and CBBT will result in a multi-faceted company strategy--building on PKG's existing foundation. Based on the first excerpt below, PKG will continue business as usual, while adding a focus to Cerebain's Alzheimer's device. What is not clear is what other company partnerships will follow next. From the second excerpt below and based on hints from IR, PKG is just the first piece of the puzzle. This is also echoed in the press release from NMS Consulting, the third excerpt. And, of course, the added benefit for PKG is that they will become part of a public company.

https://finance.yahoo.com/news/pkg-inc-ceo-excited-potential-123000531.html

Almir Garibovic, CEO of PKG Inc., stated "After 30 years in business, PKG, Inc. is thrilled that we have entered into a letter of intent to be acquired by Cerebain Biotech Corp. We are excited by this partnership because of our complementary strengths and it will enable us to fulfill our vision and values, while we continue to provide our customers with innovative design, technologies and manufacturing capabilities as never before."

Eric Clemons, CEO of Cerebain, added "We are committed to evaluating both Companies strategic core competencies to enhance value for our shareholders while maintaining our focus on the continued development of Cerebain’s device for the treatment of Alzheimer’s Disease as well as aggressively managing PKG’s current operations."

https://www.businesswire.com/news/home/20201125005429/en/

PKG Inc. intends to fully transition company ownership to Cerebain Biotech Corporation in an acquisition that began in the middle of this year. Upon completion, under the Cerebain Biotech umbrella, PKG Inc. will continue its support in mass-producing large volumes of the FDA-cleared ClearMask™. Almir Garibovic stated "We are proud to help ClearMask fight against the pandemic with a smile on our face that everyone can see.

https://nmsconsulting.com/nms-consulting-selected-as-strategic-advisor-to-cerebain-biotech-corp-for-acquisition-project/

Trevor M. Saliba, Managing Partner and Global Head of Private Equity, M&A, and Strategy of NMS said, “We are very excited to continue working with Cerebain on this mandate. Having them as our client since 2018, we have had the privilege of working with them on various initiatives in preparation of their growth strategy. The acquisition of PKG begins the implementation of their long-term business plan.”